Pharmaceuticals news continually updated from thousands of sources around the net.
Trending on the Topix Network
Together with the Danish Ministry of Environment, Novo Nordisk has released the pharmaceutical industry's first Environmental Profit and Loss account identifying the costs and areas for reduction related to water consumption, GHG emissions and air pollution.
As research becomes increasingly specialized, pharmaceutical companies many not have exactly the right expertise in house to push a project forward.
More than 20% of Americans regularly consume prescribed drugs related to mental health issues, earning contemporary America the nickname, "the Prozac Generation."
Bristol-Myers Squibb is to close its manufacturing facility in Cruiserath, Co Dublin, by the end of 2015 with the loss of 130 jobs.
Shares of Teva Pharmaceutical Industries opened at 49.80 on Thursday. Teva Pharmaceutical Industries has a one year low of $36.26 and a one year high of $50.70.
Based on its current expectations, Patheon anticipates the following results for its first-quarter ended Because Patheon's results of operations for the first quarter of fiscal 2014 have not yet been finalized, the preliminary results included in this press release are subject to change as a result of the period-end closing process and review of ... (more)
Bristol-Myers Squibb Co.' s experimental HIV drug controlled the virus as well as the company's older treatment Reyataz in a study that suggests the medicine may help difficult-to-treat patients.
As a next step in a series of corporate governance modifications, McKesson Corporation today announced that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29, 2014.
Barclays analyst Eric Percher began coverage on the US Health Care Distribution and Tech industry Wednesday morning, including coverage initiation on Cardinal Health with an Overweight rating and price target of $79.
Mylan Insider Anthony Mauro unloaded 20,000 shares of the stock on the open market in a transaction dated Monday, March 3rd.
Dr. Steven Nissen, chairman of the Cleveland Clinic's department of cardiovascular medicine, recently spoke at the "Focus on HeArt" symposium at the Frist Center for the Visual Arts in downtown Nashville.
We've received the tips and now there's some confirmation about cuts at New York-based Publicis Kaplan Thaler.
Late last month, Healthways' activist investor Boston-based North Tide Capital threw down the gauntlet again.
READING, Mass., March 4, 2014 /PRNewswire/ -- Physicians Interactive , the leading provider of online and mobile clinical resources and solutions for healthcare professionals , and McKesson Patient Relationship Solutions , a leading provider of pharmaceutical manufacturer-sponsored patient adherence programs, are collaborating to jointly deliver ... (more)
Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to EvistaA Tablets, 60 mg, in the United States.
"As we continue to focus on growing our business in the U.S., it is a key corporate objective to add seasoned executives in critical areas," said Doug Drysdale, Pernix's President and Chief Executive Officer.